News
Anal Cancer
Bladder Cancer
Bone Cancer
Brain Cancer
Breast Cancer
Cancer of Unknown Primary
Cervical Cancer
Colon Cancer
Esophageal Cancer
Gastric Cancer
GIST
Head & Neck Cancer
Hodgkins Lymphoma
Leukemia
Acute Leukemia
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Liver Cancer
Lung Cancer
Melanoma
Mesothelioma
Multiple Myeloma
Myelodysplastic Syndrome
MPN-PV-ET-MF
Neuroblastoma
Neuroendocrine Tumors
Non Hodgkins Lymphoma
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Renal Cancer
Rectal Cancer
Sarcoma
Skin Care
Skin Cancer
Testicular Cancer
Thyroid Cancer
Triple Negative Breast Cancer
Uterine Cancer
About Us
Advertising
News
Newly Diagnosed
Treatment & Care
Survivorship
Join the Community
Newsletter
Search
Breast Cancer Treatment
September 1, 2025
Understanding Surgery for Breast Cancer
Charles H. Weaver, MD
August 29, 2025
Side Effects and New CDK Inhibitor Class of Breast Cancer Drugs
Charles H. Weaver, MD
August 29, 2025
Oncotype Recurrence Score Test-What You Need to Know
Charles H. Weaver, MD
August 27, 2025
Endocrine – Hormone Therapy for Early Stage Breast Cancer
Charles H. Weaver, MD
June 4, 2025
Breast Cancer Overview
Charles H. Weaver, MD
April 1, 2025
Early Study Demonstrates Patritumab Deruxtecan Activity in Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Charles H. Weaver, MD
September 30, 2023
Breast Cancer – Are You Aware?
Charles H. Weaver, MD
August 31, 2023
Patritumab Deruxtecan Shows Promise in HER3-Expressing Metastatic Breast Cancer
Charles H. Weaver, MD
April 5, 2023
CA 15-3 Breast Tumor Marker
Charles H. Weaver, MD
March 1, 2022
Elacestrant Hormone Therapy for Advanced Breast Cancer
Charles H. Weaver, MD
October 25, 2021
Ki 67 Biomarker and Breast Cancer
Charles H. Weaver, MD
March 7, 2020
Hispanic Women Speak Out About Breast Cancer
Charles H. Weaver, MD
1
2
Next Page
Loading Comments...
Write a Comment...
Email (Required)
Name (Required)
Website